⚡ Quick Answer — What is Glinate?
Glinate is a brand of nateglinide (120 mg), a meglitinide (“glinide”) used for type 2 diabetes. Like sulfonylureas, glinides stimulate pancreatic insulin release by closing KATP channels — but much faster and for a much shorter time. The clinical niche: post-meal glucose spikes. Take 1–15 minutes before each main meal; skip the dose if you skip the meal (“no meal, no pill”). Even faster onset than repaglinide. Weaker HbA1c effect (0.5–0.8 points) but very clean post-meal action. HbA1c reduction: 0.5–1.0 percentage points. Hypoglycaemia risk is much lower than sulfonylureas because action is short. Main side effects: mild hypoglycaemia, weight gain (1–2 kg), upper respiratory infection. Avoid in type 1 diabetes, DKA, severe hepatic impairment.
📦 Every order is covered by our Reshipment Assurance Policy — if your parcel does not arrive within 20 business days, we reship it.
Why order from MedsBase
Our generic medications are sourced from WHO-GMP certified manufacturers and shipped worldwide in discreet, plain packaging — no medication name on the parcel exterior. Card payments are routed through a regulated processor (statement descriptors include a regulated card-payment processor — never “MedsBase” or any medication name). Crypto and SEPA bank transfer are also accepted. Every order is backed by our Reshipment Assurance Policy.
What Is Glinate?
Glinate is an oral antidiabetic medicine containing nateglinide (120 mg), manufactured by Glenmark Pharmaceuticals. Available in packs of 30, 60, 90 or 180 tablets. nateglinide was first approved in 2000 and belongs to the meglitinide (or “glinide”) class — short-acting insulin secretagogues used specifically to control post-meal (postprandial) glucose rises.
Meglitinides are a useful option in patients with mainly post-meal hyperglycaemia, irregular meal patterns (where a long-acting sulfonylurea would cause fasting hypoglycaemia), or mild renal impairment where glibenclamide cannot be used.
How Does Glinate Work?
nateglinide binds to a site on the ATP-sensitive potassium (KATP) channel of pancreatic beta cells — different from the sulfonylurea binding site but with a similar effect. Channel closure depolarises the beta cell, opens voltage-gated calcium channels, and triggers insulin release.
The key difference versus sulfonylureas is kinetics:
- Onset: 15–30 minutes
- Peak: 1 hour
- Duration of action: 3–4 hours
- Half-life: ~1.5 hours; hepatic metabolism with ~80% renal excretion of metabolites
This makes glinides excellent for matching the post-meal glucose rise but poor for fasting glucose control. Typical HbA1c reduction: 0.5–1.0 percentage points.
Dosage and Administration
Dose: 120 mg 1–30 minutes before each main meal. May be reduced to 60 mg near goal or as starting dose in mild hyperglycaemia. Skip if the meal is skipped.
- “No meal, no pill.” If you skip a meal, skip the dose — otherwise hypoglycaemia is likely.
- If you add a meal, add a dose before it.
- Take 1–30 minutes before the meal — consistent timing helps.
- Renal dosing: No dose adjustment needed in mild-to-moderate renal impairment. Use with caution in severe impairment.
- Hepatic impairment: use lower starting doses and titrate cautiously.
Side Effects
Common:
- Hypoglycaemia — less frequent and less severe than sulfonylureas, but still possible (especially if meal is delayed or skipped)
- Weight gain — 1–2 kg on average, less than sulfonylureas
- Upper respiratory infection, sinusitis, arthralgia
- Mild GI upset
Uncommon: rash, hypersensitivity, transient liver-enzyme elevation.
Drug Interactions
- Strong CYP3A4 inhibitors (ketoconazole, clarithromycin, ritonavir) and CYP2C8 inhibitors (gemfibrozil) — significantly raise repaglinide levels. Avoid combining repaglinide with gemfibrozil (risk of severe hypoglycaemia).
- Rifampicin, phenytoin, carbamazepine — reduce meglitinide levels; clinical effect may be reduced.
- Insulin, sulfonylureas, DPP-4 inhibitors, SGLT-2 inhibitors — additive glucose-lowering; monitor for hypoglycaemia.
- Non-selective beta-blockers — may mask hypoglycaemia symptoms.
- NSAIDs, high-dose salicylates, MAOIs, sulfonamides — may augment glucose-lowering effect.
- Corticosteroids, thiazides, thyroid hormones, oral contraceptives — may reduce glucose-lowering effect.
Who Should Not Take Glinate?
- Type 1 diabetes mellitus
- Diabetic ketoacidosis
- Severe hepatic impairment
- Pregnancy and breastfeeding — data limited; alternatives preferred
- Known hypersensitivity to meglitinides
- Combination with gemfibrozil (repaglinide)
Storage
Store Glinate below 30°C in a dry place. Keep out of reach of children.
Frequently Asked Questions
When would a doctor choose nateglinide over repaglinide?
Nateglinide has a faster onset and shorter duration than repaglinide, so it is sometimes chosen when post-meal spikes are the main problem and fasting glucose is already near target. Repaglinide is more commonly used because it has a greater HbA1c-lowering effect and a slightly longer duration that is easier to titrate.
What happens if I skip a meal?
Skip the Glinate dose too — the golden rule for glinides is “no meal, no pill.” Taking Glinate without eating is the most common cause of hypoglycaemia on this drug.
Can I take Glinate with metformin?
Yes — glinides are commonly added to metformin when post-meal glucose spikes are high. The combination has additive HbA1c effect (0.8–1.2 points extra) without the fasting hypoglycaemia risk of a long-acting sulfonylurea.
Does Glinate cause weight gain?
Mild weight gain of 1–2 kg is typical — less than sulfonylureas but more than metformin, DPP-4 inhibitors, or SGLT-2 inhibitors.
Can I drink alcohol while taking Glinate?
Moderate alcohol with food is usually safe. Avoid binge drinking and alcohol on an empty stomach — both raise hypoglycaemia risk.
Is Glinate suitable if I have kidney problems?
Repaglinide is the preferred meglitinide in renal impairment because it is cleared almost entirely by the liver. Nateglinide has renally-excreted metabolites and needs more caution in severe CKD.
Where can I buy Glinate online?
You can order Glinate (120 mg) from MedsBase in packs of 30, 60, 90 or 180 tablets. We ship worldwide, with discreet packaging and genuine WHO-GMP certified manufacturer stock.
Related Diabetes Medications
- Glycomet SR — Metformin sustained-release
- Januvia — Sitagliptin (DPP-4 inhibitor)
- Jardiance — Empagliflozin (SGLT-2 inhibitor)
- Amaryl — Glimepiride (sulfonylurea alternative)
- Glucobay — Acarbose (α-glucosidase alternative)
- Browse all Diabetes Medications
Related Alternatives
Other products in Chronic Conditions that customers also view:





























Recensioner
Det finns inga recensioner än